ホーム › アルツハイマー病 › ミズーリ州 › St. Louis
St. Louis、MOにおけるアルツハイマー病の臨床試験
St. Louisとその周辺地域（約30マイル以内）の拠点で、アルツハイマー病に関する22件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Dominantly Inherited Alzheimer Network (DIAN)
被験者募集中観察研究健康なボランティア歓迎
- Washington University in St. Louis School of Medicine, St Louis
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
被験者募集中第4相
- Tekton Research Saint Louis Psychiatry, St Louis
- Psympatica, LLC, St Louis
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
被験者募集中第3相
- Tekton Research, LLC - Saint Louis Psychiatry - PPDS, St Louis
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
被験者募集中第3相
- Washington University School of MedicineClinical Translational Research Unit, St Louis
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
被験者募集中第3相
- Local Institution - 1667, St Louis
Study to Understand Novel Biomarkers in Researching Dementia
被験者募集中観察研究健康なボランティア歓迎
- Washington University School of Medicine, St Louis
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
被験者募集中第3相
- Washington University in St. Louis, St Louis
Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis
被験者募集中第4相
- Washington University in St. Louis, St Louis
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
被験者募集中第2/3相健康なボランティア歓迎
- Washington University in St. Louis, St Louis
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
被験者募集中第2/3相健康なボランティア歓迎
- Washington University in St. Louis, St Louis
Sleep Trial to Prevent Alzheimer's Disease
被験者募集中第2相健康なボランティア歓迎
- Washington University School of Medicine, St Louis
DORA and LP in Alzheimer's Disease Biomarkers
被験者募集中第2相健康なボランティア歓迎
- Washington University in St. Louis, School of Medicine, St Louis
Investigation of Inflammation in Alzheimer's Disease and Related Dementias (ADRD) Using [11C]-CS1P1
被験者募集中観察研究健康なボランティア歓迎
- Washington University School of Medicine, St Louis
Beta Amyloid PET Imaging for Alzheimer Disease With [18F]-Fluselenamyl
被験者募集中観察研究健康なボランティア歓迎
- Washington University School of Medicine, St Louis
F 18 T807 Tau PET Imaging of Alzheimer's Disease
被験者募集中観察研究
- Washington University School of Medicine, St Louis
Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)
被験者募集中観察研究
- Washington University School of Medicine, St Louis
Trial-Ready Cohort-Down Syndrome (TRC-DS)
被験者募集中観察研究
- Washington University, St. Louis, St Louis
Late Onset Alzheimer's Disease
被験者募集中観察研究健康なボランティア歓迎
- Joanne Norton, St Louis
Alzheimer"s Imaging Biomarkers in Obesity
被験者募集中観察研究健康なボランティア歓迎
- Washington University School of Medicine, St Louis
Just-In-Time Adaptive Interventions (JITAIs) in a Digital Mental Health Intervention for Middle-Aged and Older Adults With Chronic Pain
被験者募集中
- Washington University in St. Louis School of Medicine, St Louis
A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK
被験者募集中第1相
- Washington University in St. Louis, St Louis
Imaging Biomarkers in Preclinical and Symptomatic AD
被験者募集中観察研究
- Washington University School of Medicine, St Louis
他の都市におけるアルツハイマー病の試験
- Boston, MA26件の研究
- Orlando, FL25件の研究
- New York City, NY21件の研究
- Miami, FL20件の研究
- Tampa, FL17件の研究
- Atlanta, GA16件の研究
- The Villages, FL15件の研究
- Philadelphia, PA15件の研究
- Phoenix, AZ15件の研究
- Indianapolis, IN14件の研究
- Los Angeles, CA14件の研究
- West Palm Beach, FL13件の研究
St. Louisにおける他の研究
- 非小細胞肺癌73件の研究
- 乳がん64件の研究
- 転移性癌54件の研究
- 大腸癌50件の研究
- がん（全種類）46件の研究
- 前立腺がん46件の研究
- 肺がん39件の研究
- 卵巣がん38件の研究
- 膵臓がん33件の研究
- 子宮内膜がん29件の研究
- 頭頸部扁平上皮癌28件の研究
- 心不全26件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。